Publication Series
In this section you will find Publication Series market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
Triple Analysis: Breast Cancer, Angiogenesis and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Leukemia and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lymphoma, Melanoma and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Breast Cancer, Apoptosis and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Apoptosis, Angiogenesis and Protein Kinase Inhibitors. Learn More -
Triple Analysis: Leukemia, Melanoma and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Cancer Vaccines, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors and by the compound strategy of Antibodies. Learn More -
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Pancreatic Cancer and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Leukemia, Lung Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Colorectal Cancer, Melanoma and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Melanoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Lymphoma, Prostate Cancer and Protein Kinase Inhibitors
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the mechanism/target/effect of Protein Kinase Inhibitors. Learn More -
Triple Analysis: Pancreatic Cancer, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Pancreatic Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Peptides
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Protein Kinase Inhibitors and by the compound strategy of Peptides. Learn More -
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More -
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies
€3,450.00Published by BioSeeker Group on May 1st, 2012This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Learn More